| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $29.37M | - | |
| CFO | 248.6K | $2.66M | - | |
| Dir | 124.4K | $1.33M | - | |
| CEO | 70.8K | $758.0K | - | |
| Dir | 63.1K | $674.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Chris A Rallis60 | Director | Sell | 333 | $7.99 | $2,660.67 | -1.1% | +15.5% | +1.6% | |
| May 4, 2020 | Southpoint Capital Advisors LP47 | 10% Owner | Buy | 80,000 | $6.25 | $500,000.00 | +2.0% | - | - | |
| Apr 30, 2020 | Spa Essetifin | 10% Owner | Buy | 768,000 | $6.25 | $4,800,000.00 | +23.8% | - | - | |
| Mar 28, 2018 | Manchester Management Pr, LLC | 10% Owner | Sell | 914,745 | $10.61 | $9,704,023.36 | -42.3% | - | - | |
| Mar 6, 2018 | Manchester Management Pr, LLC | 10% Owner | Sell | 70,100 | $9.22 | $646,577.00 | -3.1% | - | - | |
| Dec 12, 2017 | Spa Essetifin | 10% Owner | Buy | 294,115 | $8.50 | $2,499,977.50 | +10.0% | - | - | |
| Oct 24, 2017 | Manchester Management Pr, LLC | 10% Owner | Buy | 79,830 | $7.28 | $581,309.80 | +5.0% | - | - | |
| Dec 30, 2016 | Manchester Management Pr, LLC | 10% Owner | Buy | 96,000 | $2.01 | $192,640.00 | +6.2% | - | - | |
| Aug 4, 2016 | Manchester Management Pr, LLC | 10% Owner | Buy | 190,850 | $2.06 | $392,528.00 | +13.7% | - | - |